6143 POSTER Study 20050203/PRIME – Effect of Post-Progression Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody (mAb) Therapy in Patients With Wild-Type (WT) KRas Metastatic Colorectal Cancer (mCRC) - Siena, S.; Douillard, J.Y.; Cassidy, J.; Tabernero, J.; Burkes, R.; Barugel, M.E.; Humblet, Y.; Cunningham, D.; Yu, H.; Krishnan, K. (European Journal of Cancer, 2011)